Su Yuanhao, Jin Yi
Department of General Surgery, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Cell and Gene Research Therapy Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Transl Cancer Res. 2025 Mar 30;14(3):2125-2149. doi: 10.21037/tcr-24-1038. Epub 2025 Mar 27.
BACKGROUND AND OBJECTIVE: In recent years, research on the relationship between papillary thyroid carcinoma (PTC) and long non-coding RNAs (lncRNAs) has been burgeoning. However, there has not been an analysis of the regulatory mechanisms of these lncRNAs in all tumors, nor a comprehensive categorization and comparison of these mechanisms. This review aims to uncover whether PTC-related lncRNAs also play an important role in other tumors and to identify a common pattern of action. METHODS: We conducted a statistical analysis of lncRNAs related to PTC that have been reported during the period from Jan 2022 to May 2024 through searching in the Embase, Web of Science, and PubMed databases, focusing on those with greater research value. Using them as the focal points of our study, we compiled data on their different regulatory mechanisms across various malignant tumors, emphasizing key findings. KEY CONTENT AND FINDINGS: This comprehensive analysis not only provides valuable insights into potential regulatory mechanisms of these lncRNAs in PTC but also serves as a reference for exploring their broader regulatory networks within cancer. The principal discovery is that lncRNAs associated with PTC can competitively interact with microRNAs (miRNAs). This interaction influences miRNA-targeted messenger RNA (mRNA) and the expression of cancer-related proteins, ultimately facilitating the progression of PTC as well as other malignant tumors. CONCLUSIONS: The lncRNAs associated with PTC exert regulatory functions in other malignancies as well and possess similar regulatory mechanisms. This provides a molecular basis for the future development of relevant targeted therapies.
背景与目的:近年来,甲状腺乳头状癌(PTC)与长链非编码RNA(lncRNA)之间关系的研究蓬勃发展。然而,尚未对这些lncRNA在所有肿瘤中的调控机制进行分析,也未对这些机制进行全面的分类和比较。本综述旨在揭示与PTC相关的lncRNA在其他肿瘤中是否也发挥重要作用,并确定其共同的作用模式。 方法:我们通过检索Embase、Web of Science和PubMed数据库,对2022年1月至2024年5月期间报道的与PTC相关的lncRNA进行了统计分析,重点关注那些具有较高研究价值的lncRNA。以它们作为研究重点,我们汇总了它们在各种恶性肿瘤中的不同调控机制的数据,突出了关键发现。 关键内容与发现:这一全面分析不仅为这些lncRNA在PTC中的潜在调控机制提供了有价值的见解,也为探索它们在癌症中的更广泛调控网络提供了参考。主要发现是,与PTC相关的lncRNA可以与微小RNA(miRNA)发生竞争性相互作用。这种相互作用影响miRNA靶向的信使核糖核酸(mRNA)以及癌症相关蛋白的表达,最终促进PTC以及其他恶性肿瘤的进展。 结论:与PTC相关的lncRNA在其他恶性肿瘤中也发挥调控作用,且具有相似的调控机制。这为未来相关靶向治疗的发展提供了分子基础。
Semin Cancer Biol. 2022-8
Biochem Biophys Rep. 2024-2-29
Pathol Res Pract. 2024-4
Biochem Biophys Rep. 2024-2-29
Aging (Albany NY). 2023-12-18
Nat Rev Genet. 2024-3
J Orthop Surg Res. 2023-11-8
Naunyn Schmiedebergs Arch Pharmacol. 2024-5